Given the strong hereditary link found in the prevalence of allergic disease, allergies are likely to remain a feature of the Australian consumer health landscape over the forecast period. According to the 2020 report, “Walking the allergy tightrope”, released following an inquiry by the Health, Aged Care and Sport Committee (under the parliamentary House of Representatives) into allergies and anaphylaxis, research suggests that a history of both parents having allergic disease equates to offspring having up to 60% chance of developing allergic disease.
OTC medications, in particular, paediatric consumer health products and those in related categories targeting infants and children, are likely to be subject to increased scrutiny and distribution restrictions over the forecast period. In line with key trends emerging in 2023-2024, chewable tablets of paediatric acetaminophen will be subject to packaging content limitations per distribution channel from February 2025, with the maximum pack size available for sale via supermarkets being 16 tablets.
The proposed merger of ASX-listed Sigma Healthcare with privately-owned retail pharmacy chain Chemist Warehouse Group, to form a company worth AUD8.8 billion, is currently subject to review by the Australian Competition and Consumer Commission (ACCC), with the corporate regulator flagging significant concerns about the deal.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Paediatric consumer health industry in Australia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Paediatric consumer health industry in Australia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Paediatric consumer health
Products only specifically designed, marketed and labelled for children's symptoms. Include paediatric analgesics, paediatric cough, cold and allergy remedies, paediatric digestive remedies, paediatric medicated skin care, nappy (diaper) rash treatments, paediatric vitamins and dietary supplements.
See all of our definitionsThis report originates from Passport, our Paediatric consumer health research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!